ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P 500
5,070.86
-0.89%
US Tech 100
17,127.40
-1.05%
Dow Jones
37,997.09
-1.01%
Brent Oil
86.245
-1.19%
Bitcoin
60,295.56
-5.55%
Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ

  6. UroGen Pharma Ltd (URGN) Quote

UroGen Pharma Ltd

UroGen Pharma Ltd (URGN)

NASDAQ
13.87
-0.17
( -1.21% )
Updated: 14:19:21
Delayed by 15 minutes

Unlock more advanced trading tools

Join ADVFN today

Key stats and details

Current Price
13.87
Bid
13.86
Ask
13.91
Volume
125,259
13.81 Day's Range 14.15
8.69 52 Week Range 24.13
Market Cap
474.979M
Previous Close
14.04
Open
14.00
Last Trade
1
@
13.885
Last Trade Time
14:19:47
Financial Volume
$ 1,749,680
VWAP
13.9685
Average Volume (3m)
359,007
Shares Outstanding
34,122,087
Dividend Yield
-
PE Ratio
-4.65
Earnings Per Share (EPS)
-3
Revenue
82.71M
Net Profit
-102.24M

About UroGen Pharma Ltd

UroGen Pharma Ltd is a clinical stage biopharmaceutical company focused on developing novel therapies designed to change the standard of care for urological pathologies. The company has an innovative and broad pipeline of product candidates that can overcome the deficiencies of current treatment opt... UroGen Pharma Ltd is a clinical stage biopharmaceutical company focused on developing novel therapies designed to change the standard of care for urological pathologies. The company has an innovative and broad pipeline of product candidates that can overcome the deficiencies of current treatment options for a variety of urological conditions with a focus on uro-oncology. Its lead product candidates, UGN-101 and UGN-102, are proprietary formulations of the chemotherapy drug Mitomycin C, or MMC, a generic drug, which is used off-label for urothelial cancer treatment only in a water-based formulation as an adjuvant, or supplemental post-surgery, therapy. Show more

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Website
www.urogen.com
Headquarters
Ra'anana, Center, Isr
Founded
1970
UroGen Pharma Ltd is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker URGN. The last closing price for UroGen Pharma was $14.04. Over the last year, UroGen Pharma shares have traded in a share price range of $ 8.69 to $ 24.13.

UroGen Pharma currently has 34,122,087 shares outstanding. The market capitalization of UroGen Pharma is $474.98 million. UroGen Pharma has a price to earnings ratio (PE ratio) of -4.65.

URGN Latest News

More News

UroGen Announces New Data Presentations at the American Urological Association 2024 Annual Meeting Highlighting Clinical Benefits of Our Portfolio for Urothelial Cancers

Subgroup analysis of the UGN-102 ATLAS Trial in patients with new versus recurrent low-grade intermediate-risk non-muscle invasive bladder cancer (LG-IR-NMIBC) Three independent long-term...

April 17 2024
Business Wire

UroGen Announces FDA Acceptance of Investigational New Drug Application for UGN-103, a Next Generation Mitomycin-Based Formulation for Low-Grade Intermediate-Risk Non-Muscle Invasive Bladder Cancer

UroGen plans to initiate a Phase 3 study to explore the safety and efficacy of UGN-103 in 2024 Anticipated advantages include a new 80 mg mitomycin dosage strength that may considerably shorten...

April 15 2024
Business Wire

UroGen Pharma Files Patent Infringement Action Against Teva Pharmaceuticals

UroGen Pharma Ltd. (Nasdaq: URGN), a biotech company dedicated to developing and commercializing novel solutions that treat urothelial and specialty cancers, today announced that it has filed a...

April 03 2024
Business Wire

UroGen Pharma Delivers Double Digit JELMYTO® Growth and Prepares for the Next Phase of the Company with on Track Rolling Submission of UGN-102

Initiated submission of a rolling NDA to the FDA for UGN-102; 12-month duration of response data from ENVISION expected to support completion of NDA submission Announced next-generation novel...

March 14 2024
Business Wire

UroGen Pharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

UroGen Pharma Ltd. (Nasdaq: URGN), a biotech company dedicated to developing and commercializing innovative solutions that treat urothelial and specialty cancers, today announced the grants of...

March 08 2024
Business Wire

UroGen Pharma to Report Fourth Quarter and Full-Year 2023 Financial Results on Thursday, March 14, 2024

Conference Call and Webcast Scheduled for Thursday, March 14, 2024, at 10:00 AM ET UroGen Pharma Ltd. (Nasdaq: URGN), a biotech company dedicated to developing and commercializing innovative...

March 04 2024
Business Wire

Form 8-K - Current report

March 04 2024
Edgar (US Regulatory)

Form 8-K - Current report

March 01 2024
Edgar (US Regulatory)
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-0.53-3.6805555555614.414.8513.6916620014.15711701CS
40.0450.32549728752313.82515.512.3729373414.25613814CS
12-2.03-12.767295597515.919.8712.3735900716.19637195CS
262.6924.06082289811.1819.8710.6331577215.18405547CS
522.2819.672131147511.5924.138.6938144616.1690226CS
156-6.13-30.652024.134.8520615714.03982768CS
260-22.86-62.237952627336.7339.974.8519803618.37857038CS

Market Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
AKLIAkili Inc
$ 0.3878
(65.09%)
81.53M
IMCCIM Cannabis Corporation
$ 0.89201
(59.29%)
5.11M
GMMGlobal Mofy Metaverse Ltd
$ 1.475
(58.55%)
75.51M
CYCCCyclacel Pharmaceuticals Inc
$ 2.0675
(52.02%)
19.86M
WGSGeneDx Holdings Corporation
$ 16.225
(47.50%)
6.07M
LICNLichen China Limited
$ 1.3589
(-33.06%)
1.1M
CETXCemtrex Inc
$ 1.2457
(-30.02%)
379.31k
NRXPNRX Pharmaceuticals Inc
$ 2.67
(-24.79%)
790.73k
TCJHTop KingWin Ltd
$ 0.555049
(-22.65%)
312.77k
OPGNOpGen Inc
$ 0.42
(-21.50%)
778.54k
TSLATesla Inc
$ 185.7499
(-4.28%)
98.11M
SQQQProShares UltraPro Short QQQ
$ 11.6521
(3.02%)
90.87M
EGOXNext e GO NV
$ 0.0322
(16.67%)
87.54M
AGBAAGBA Group Holding Ltd
$ 3.06
(30.21%)
87.47M
JAGXJaguar Health Inc
$ 0.2283
(9.76%)
84.64M

Discussion

View Full Feed
Twilson Twilson 1 minute ago
What does the price of pot have to do with the market?
Longstrongsilver Longstrongsilver 1 minute ago
Makes sense because I didn’t see it coming from the one I mentioned. Not for another 100-300% unless they’re idjits
IGPK
carlson carlson 1 minute ago
If BTC goes to 150,000 USD would CGAC rise significantly?
CGAC
vlispxpert vlispxpert 1 minute ago
I N T J, started .96, beat to hell IPO:

https://schrts.co/TJWVeGzQ
StockStarGucci StockStarGucci 1 minute ago
Nice hits on .03
CBDW
uber darthium uber darthium 1 minute ago
Again, I do not disagree, I have been reading everything available I can find about the electrostatic propulsion idea. I think ( in my opinion ) Holcomb is reading reactive power off the capacitors as others here have stated. The lack of documentation is astounding.

I am a big fan o
ASRE
imafan imafan 1 minute ago
SHORTS MUST BE SCARED-SHITLESS TO EQUATE THE OTCMARKETS' NORMAL REVIEW-PERIOD WITH HHSE CEO (SO-CALLED) "STRIKING OUT".

US LONGS SEE RIGHT THROUGH EVERY SHORT TACTIC, METHOD AND PSYOPS, AND WE LAUGH AT IT. PURE ENTERTAINMENT FOR US. IMAGINE SPENDING UP TO 14 YEARS ON HHSE MESSAGE BOAR
HHSE
jimmybob jimmybob 1 minute ago
IIPR calls
jimmybob jimmybob 2 minutes ago
POTTTTT
op9171787 op9171787 2 minutes ago
surprise, of course, nothing.
IFAN
Longstrongsilver Longstrongsilver 2 minutes ago
To be fair it’s *they’re both times lol but yes I get your meaning
DJT
TKS PARTY TKS PARTY 2 minutes ago
Not one statement except the stupid part about the jet fuel, since WOWZA or Trucking Towers has anything to do with Jet fuel. Let's go with the Amazon story line ground floor opportunity that sounds great, just .86 cents a share. For clarification jet fuel is not being tested anywhere. I just got o
ECSL
monocle monocle 2 minutes ago
Close to 3 years ago, Mark spoke of looking for a cornerstone investor to put up 25 million to get the ball rolling. An institutional investor stepping up with that much late last year could have meant a completed feasibility study by now.

Just don't understand why Yorkville was a ne
NB
trademax42 trademax42 2 minutes ago
I believe there is an unfilled gap at $2.47 from this morning trades. Sometimes MMs tend to close gaps on the charts and at other times they may not.....especially if its a runaway gap. We'll see.

waiting for two,s before i add more.
AGBA
delerious1 delerious1 2 minutes ago
Things are heating up in the Basher Index
GVSI
HonkyStonk HonkyStonk 2 minutes ago
New 52 week low
SPQS
jbsliverer jbsliverer 2 minutes ago
Fox News Quietly Deletes Hunter Biden ‘Mock Trial’ Special Following Lawsuit Threat
The conservative cable giant has quickly moved to comply with the presidential scion’s demands.
https://www.thedailybeast.com/fox-news-quietly-deletes-hunter-biden-mock-trial-special-following-lawsuit-t
Gunny Gunny 2 minutes ago
If you just see the "Now" then we are diluted and depressed. If you see the investment in the "Now, Soon and Later" you will see the opportunity to buy low for new and seasoned investors as well as the removal of the corporate investors. Both are a benefit to us. Once these companies are divested a
CRTG
SF971 SF971 2 minutes ago
Still undervalued at $3 M Market Cap vs. $7.4 M Revenue.
YCRM
Money hunt Money hunt 2 minutes ago
Get ready for news dude!!!!
SPCB
Elroy Jetson Elroy Jetson 3 minutes ago
China's best, a premier Hongshi the limo always used by Xi Jinping, destroyed in a charging fire - https://www.hongqi-auto.com/

Yes, China is making a lot of chargers.

https://www.siliconinvestor.com/public/4188495_060cfa96fe83d6c6299e11374b717cf0.jpg
tradernewstip tradernewstip 3 minutes ago
$RONN RONN Motor Group has put in place a world-class executive team of experienced automotive and marketing experts with a single mind, "Create sustainable energy for mobility and a better quality of life." https://www.ronnmotorgroup.com/about
RONN
capgain capgain 3 minutes ago
Happy birthday Murray!

Your Recent History

NASDAQ
URGN
UroGen Pharma
Delayed Upgrade Clock
ADVFN Logo

United States
Company
Business
Popular
Get The App

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved